Treatment of hypertension in the elderly

II. Cognitive and behavioral function. Results of a department of veterans affairs cooperative study

Gerald Goldstein, Barry J. Materson, William Cushman, Domenic J. Reda, Edward D. Freis, Eli A. Ramirez, Frederick N. Talmers, Thomas J. White, Stewart Nunn, Robert H. Chapman, Ibrahim Khatri, Harold Schnaper, J. R. Thomas, William G. Henderson, Carol Fye

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

This study was designed to determine whether blood pressure reduction, per se, causes adverse effects on cognitive and behavioral function in elderly hypertensive patients. Men with mild-to-moderate diastolic hypertension who had passed their 60th birthday were entered into the trial. After a placebo washout period, they were assigned in a randomized, double-blind manner to one of two groups receiving hydrochlorothiazide (either 25 mg once or twice daily or 50 mg once or twice daily). Responders entered a 1-year maintenance period. Nonresponders were randomly assigned to double-blind treatment with hydralazine, methyldopa, metoprolol, or reserpine added to the diuretic therapy. During the placebo and treatment periods, patients underwent a battery of psychometric tests designed to assess cognitive function, motor skills, memory, and affect. A separate questionnaire assessed the patient's ability to perform activities of daily living. A subset of patients blindly being treated with placebo received the same battery of tests as a control for practice effect. The results showed that there was similar improvement on the psychometric tests between those patients whose blood pressure was successfully reduced and the placebo-treated control group. Therefore, the practice effect did not obscure a true deterioration in function. There were no substantive differences between the lower and higher doses of diuretic or among the four drugs added to the diuretic, although there were qualitative differences in side effects. We conclude that blood pressure reduction, per se, does not adversely affect cognitive and behavioral function in elderly hypertensive patients and that antihypertensive treatment is safe and effective in these patients.

Original languageEnglish (US)
Pages (from-to)361-369
Number of pages9
JournalHypertension
Volume15
Issue number4
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Veterans
Cognition
Hypertension
Placebos
Diuretics
Blood Pressure
Psychometrics
Therapeutics
Methyldopa
Hydralazine
Metoprolol
Motor Skills
Hydrochlorothiazide
Aptitude
Reserpine
Activities of Daily Living
Antihypertensive Agents
Maintenance
Control Groups
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Treatment of hypertension in the elderly : II. Cognitive and behavioral function. Results of a department of veterans affairs cooperative study. / Goldstein, Gerald; Materson, Barry J.; Cushman, William; Reda, Domenic J.; Freis, Edward D.; Ramirez, Eli A.; Talmers, Frederick N.; White, Thomas J.; Nunn, Stewart; Chapman, Robert H.; Khatri, Ibrahim; Schnaper, Harold; Thomas, J. R.; Henderson, William G.; Fye, Carol.

In: Hypertension, Vol. 15, No. 4, 01.01.1990, p. 361-369.

Research output: Contribution to journalArticle

Goldstein, G, Materson, BJ, Cushman, W, Reda, DJ, Freis, ED, Ramirez, EA, Talmers, FN, White, TJ, Nunn, S, Chapman, RH, Khatri, I, Schnaper, H, Thomas, JR, Henderson, WG & Fye, C 1990, 'Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a department of veterans affairs cooperative study', Hypertension, vol. 15, no. 4, pp. 361-369. https://doi.org/10.1161/01.HYP.15.4.361
Goldstein, Gerald ; Materson, Barry J. ; Cushman, William ; Reda, Domenic J. ; Freis, Edward D. ; Ramirez, Eli A. ; Talmers, Frederick N. ; White, Thomas J. ; Nunn, Stewart ; Chapman, Robert H. ; Khatri, Ibrahim ; Schnaper, Harold ; Thomas, J. R. ; Henderson, William G. ; Fye, Carol. / Treatment of hypertension in the elderly : II. Cognitive and behavioral function. Results of a department of veterans affairs cooperative study. In: Hypertension. 1990 ; Vol. 15, No. 4. pp. 361-369.
@article{59db0ee5ad1f420ba3b2bba22d30ccf3,
title = "Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a department of veterans affairs cooperative study",
abstract = "This study was designed to determine whether blood pressure reduction, per se, causes adverse effects on cognitive and behavioral function in elderly hypertensive patients. Men with mild-to-moderate diastolic hypertension who had passed their 60th birthday were entered into the trial. After a placebo washout period, they were assigned in a randomized, double-blind manner to one of two groups receiving hydrochlorothiazide (either 25 mg once or twice daily or 50 mg once or twice daily). Responders entered a 1-year maintenance period. Nonresponders were randomly assigned to double-blind treatment with hydralazine, methyldopa, metoprolol, or reserpine added to the diuretic therapy. During the placebo and treatment periods, patients underwent a battery of psychometric tests designed to assess cognitive function, motor skills, memory, and affect. A separate questionnaire assessed the patient's ability to perform activities of daily living. A subset of patients blindly being treated with placebo received the same battery of tests as a control for practice effect. The results showed that there was similar improvement on the psychometric tests between those patients whose blood pressure was successfully reduced and the placebo-treated control group. Therefore, the practice effect did not obscure a true deterioration in function. There were no substantive differences between the lower and higher doses of diuretic or among the four drugs added to the diuretic, although there were qualitative differences in side effects. We conclude that blood pressure reduction, per se, does not adversely affect cognitive and behavioral function in elderly hypertensive patients and that antihypertensive treatment is safe and effective in these patients.",
author = "Gerald Goldstein and Materson, {Barry J.} and William Cushman and Reda, {Domenic J.} and Freis, {Edward D.} and Ramirez, {Eli A.} and Talmers, {Frederick N.} and White, {Thomas J.} and Stewart Nunn and Chapman, {Robert H.} and Ibrahim Khatri and Harold Schnaper and Thomas, {J. R.} and Henderson, {William G.} and Carol Fye",
year = "1990",
month = "1",
day = "1",
doi = "10.1161/01.HYP.15.4.361",
language = "English (US)",
volume = "15",
pages = "361--369",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Treatment of hypertension in the elderly

T2 - II. Cognitive and behavioral function. Results of a department of veterans affairs cooperative study

AU - Goldstein, Gerald

AU - Materson, Barry J.

AU - Cushman, William

AU - Reda, Domenic J.

AU - Freis, Edward D.

AU - Ramirez, Eli A.

AU - Talmers, Frederick N.

AU - White, Thomas J.

AU - Nunn, Stewart

AU - Chapman, Robert H.

AU - Khatri, Ibrahim

AU - Schnaper, Harold

AU - Thomas, J. R.

AU - Henderson, William G.

AU - Fye, Carol

PY - 1990/1/1

Y1 - 1990/1/1

N2 - This study was designed to determine whether blood pressure reduction, per se, causes adverse effects on cognitive and behavioral function in elderly hypertensive patients. Men with mild-to-moderate diastolic hypertension who had passed their 60th birthday were entered into the trial. After a placebo washout period, they were assigned in a randomized, double-blind manner to one of two groups receiving hydrochlorothiazide (either 25 mg once or twice daily or 50 mg once or twice daily). Responders entered a 1-year maintenance period. Nonresponders were randomly assigned to double-blind treatment with hydralazine, methyldopa, metoprolol, or reserpine added to the diuretic therapy. During the placebo and treatment periods, patients underwent a battery of psychometric tests designed to assess cognitive function, motor skills, memory, and affect. A separate questionnaire assessed the patient's ability to perform activities of daily living. A subset of patients blindly being treated with placebo received the same battery of tests as a control for practice effect. The results showed that there was similar improvement on the psychometric tests between those patients whose blood pressure was successfully reduced and the placebo-treated control group. Therefore, the practice effect did not obscure a true deterioration in function. There were no substantive differences between the lower and higher doses of diuretic or among the four drugs added to the diuretic, although there were qualitative differences in side effects. We conclude that blood pressure reduction, per se, does not adversely affect cognitive and behavioral function in elderly hypertensive patients and that antihypertensive treatment is safe and effective in these patients.

AB - This study was designed to determine whether blood pressure reduction, per se, causes adverse effects on cognitive and behavioral function in elderly hypertensive patients. Men with mild-to-moderate diastolic hypertension who had passed their 60th birthday were entered into the trial. After a placebo washout period, they were assigned in a randomized, double-blind manner to one of two groups receiving hydrochlorothiazide (either 25 mg once or twice daily or 50 mg once or twice daily). Responders entered a 1-year maintenance period. Nonresponders were randomly assigned to double-blind treatment with hydralazine, methyldopa, metoprolol, or reserpine added to the diuretic therapy. During the placebo and treatment periods, patients underwent a battery of psychometric tests designed to assess cognitive function, motor skills, memory, and affect. A separate questionnaire assessed the patient's ability to perform activities of daily living. A subset of patients blindly being treated with placebo received the same battery of tests as a control for practice effect. The results showed that there was similar improvement on the psychometric tests between those patients whose blood pressure was successfully reduced and the placebo-treated control group. Therefore, the practice effect did not obscure a true deterioration in function. There were no substantive differences between the lower and higher doses of diuretic or among the four drugs added to the diuretic, although there were qualitative differences in side effects. We conclude that blood pressure reduction, per se, does not adversely affect cognitive and behavioral function in elderly hypertensive patients and that antihypertensive treatment is safe and effective in these patients.

UR - http://www.scopus.com/inward/record.url?scp=0025219286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025219286&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.15.4.361

DO - 10.1161/01.HYP.15.4.361

M3 - Article

VL - 15

SP - 361

EP - 369

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -